Jie GL - Search Results

1

MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors.

Peng LX, Jie GL, Li AN, Liu SY, Sun H, Zheng MM, Zhou JY, Zhang JT, Zhang XC, Zhou Q, Zhong WZ, Yang JJ, Tu HY, Su J, Yan HH, Wu YL. Peng LX, et al. Among authors: jie gl. Exp Hematol Oncol. 2021 Nov 10;10(1):52. doi: 10.1186/s40164-021-00245-y. Exp Hematol Oncol. 2021. PMID: 34758872 Free PMC article.

2

Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients.

Liu SY, Sun H, Zhou JY, Jie GL, Xie Z, Shao Y, Zhang X, Ye JY, Chen CX, Zhang XC, Zhou Q, Yang JJ, Wu YL. Liu SY, et al. Among authors: jie gl. Biomark Res. 2020 Jun 25;8:22. doi: 10.1186/s40364-020-00199-z. eCollection 2020. Biomark Res. 2020. PMID: 32607238 Free PMC article.

3

Epidermal growth factor receptor-targeted therapy for the treatment of non-small cell lung cancer: a review of phase II and III trials.

Lu HL, Jie GL, Wu YL. Lu HL, et al. Among authors: jie gl. Expert Opin Emerg Drugs. 2022 Jun;27(2):111-126. doi: 10.1080/14728214.2022.2063836. Epub 2022 Apr 14. Expert Opin Emerg Drugs. 2022. PMID: 35385682 Review.

4

Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients.

Tian HX, Chen ZH, Jie GL, Wang Z, Yan HH, Wu SP, Zhang SL, Lu DX, Zhang XC, Wu YL. Tian HX, et al. Among authors: jie gl. Cancer Med. 2023 Jan;12(1):396-406. doi: 10.1002/cam4.4925. Epub 2022 Jun 14. Cancer Med. 2023. PMID: 35702826 Free PMC article.

5

Toward a cure for lung cancer: important advances in operable non-small cell lung cancer.

Liu SM, Jie GL, Wu YL. Liu SM, et al. Among authors: jie gl. Sci Bull (Beijing). 2022 Jul 30;67(14):1402-1405. doi: 10.1016/j.scib.2022.06.008. Epub 2022 Jun 15. Sci Bull (Beijing). 2022. PMID: 36546178 No abstract available.

6

Longitudinal Plasma Proteomics-Derived Biomarkers Predict Response to MET Inhibitors for MET-Dysregulated NSCLC.

Jie GL, Peng LX, Zheng MM, Sun H, Wang SR, Liu SM, Yin K, Chen ZH, Tian HX, Yang JJ, Zhang XC, Tu HY, Zhou Q, Wong CCL, Wu YL. Jie GL, et al. Cancers (Basel). 2023 Jan 1;15(1):302. doi: 10.3390/cancers15010302. Cancers (Basel). 2023. PMID: 36612298 Free PMC article.

7

Novel systemic therapies in the management of tyrosine kinase inhibitor-pretreated patients with epidermal growth factor receptor-mutant non-small-cell lung cancer.

Li YS, Jie GL, Wu YL. Li YS, et al. Among authors: jie gl. Ther Adv Med Oncol. 2023 Aug 31;15:17588359231193726. doi: 10.1177/17588359231193726. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37667782 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters